000			01450 a2200373 4500
005			20250516133554.0
264		0	_c20140113
008			201401s 0 0 eng d
022			_a1464-3405
024	7		_a10.1016/j.bmcl.2013.01.020 _2doi
040			_aNLM _beng _cNLM
100	1		_aBright, Sandra A
245	0	0	_aBasic N-interlinked imipramines show apoptotic activity against malignant cells including Burkitt's lymphoma. _h[electronic resource]
260			_bBioorganic & medicinal chemistry letters _cMar 2013
300			_a1220-4 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xchemistry
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBurkitt Lymphoma _xdrug therapy
650	0	4	_aCell Death _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aHumans
650	0	4	_aImipramine _xanalogs & derivatives
650	0	4	_aSerotonin Plasma Membrane Transport Proteins _xmetabolism
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xchemistry
700	1		_aBrinkø, Anne
700	1		_aLarsen, Maja Thim
700	1		_aSinning, Steffen
700	1		_aWilliams, D Clive
700	1		_aJensen, Henrik H
773	0		_tBioorganic & medicinal chemistry letters _gvol. 23 _gno. 5 _gp. 1220-4
856	4	0	_uhttps://doi.org/10.1016/j.bmcl.2013.01.020 _zAvailable from publisher's website
999			_c22481183 _d22481183